MabVax Therapeutics Story Overview

MBVX -- USA Stock  

USD 1.15  0.21  15.44%

Macroaxis does not monitor all media channels or aggregates social signals for MabVax Therapeutics. But even though we do not provide professional-grade financial sentiment analysis on MabVax Therapeutics, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for MabVax Therapeutics. Please see also Stocks Correlation.
Mabvax Therapeutics Holdings Inc Stock Price Performance in Focus
The Business UnionStock-research Ratings MabVax Therapeutics Holdings, Inc. , Digital Ally, Inc. Analyst JournalFull coverage

Read More...   

Story Momentum

This media report from earlebusinessunion.com distributed on December 7, 2017 was a factor to the next trading day price decrease.The trading delta at closing time against the next closing price was 1.52% . The trading delta at closing time when the story was published against the current closing price is 46.25% .

Similar stores for MabVax Therapeutics

few hours ago at http://kreviewer.com 
Global X Management Co Boosted Stantec Stake Shorts at Mabvax Therapeutics Holdings Raised By ...
news
K ReviewerFull coverage
over a week ago at http://www.thecoinguild.com 
Equity Review Checking in on Shares of MabVax Therapeutics Holdings, Inc.
news
The Coin GuildFull coverage
over two weeks ago at http://www.thestreetpoint.com 
Enslaving Three Stocks MabVax Therapeutics Holdings, Inc. , Aegean Marine Petroleum Network Inc ...
Thestreet News
The Stock Street Full coverage
over three weeks ago at www.macroaxis.com 
Acquisition by Kenneth Cohen of 34250 shares of MabVax Therapeutics subject to Rule 16b-3
Macroaxis News
Filed transaction by Mabvax Therapeutics Holdi director. Grant, award or other acquisition pursuant to Rule 16b-3
over a month ago at http://thewellesleysnews.com 
Analyst Opinion Summary Gerdau SA , MabVax Therapeutics Holdings, Inc.
news
Analyst JournalFull coverage
over a month ago at www.macroaxis.com 
Purchase by Black Bear Offshore Master Fund Lp of 177058 shares of MabVax Therapeutics
Macroaxis News
Filed transaction by Mabvax Therapeutics Holdi executive. General open market or private purchase of non-derivative or derivative security
over a month ago at http://simplywall.st 
MabVax Therapeutics Holdings Inc Risks You Need To Consider Before Buying
news
Simply Wall StFull coverage
over a month ago at http://www.satprnews.com 
Investor News MabVax Therapeutics Holdings, Inc. Investor Alert Lawsuit alleges False and ...
news
satPRnews Full coverage
over a month ago at http://kaplanherald.com 
Investors Are Circling Mabvax Therapeutics Holdings Inc , What Do the Numbers Tell Us
news
Kaplan HeraldFull coverage
over two months ago at http://fintelegraph.com 
These stocks can put the shareholders at the helm Spirit AeroSystems Holdings, Inc. , MabVax Therapeutics ...
news
Financial TelegraphFull coverage
over two months ago at http://www.businesswire.com 
Glancy Prongay Murray LLP Announces Investigation on Behalf of MabVax Therapeutics Holdings, Inc. Investors .....
businesswire News
Business Wire Full coverage
over three months ago at www.macroaxis.com 
Purchase by Black Bear Offshore Master Fund Lp of 59400 shares of MabVax Therapeutics
Macroaxis News
Filed transaction by Mabvax Therapeutics Holdi executive. General open market or private purchase of non-derivative or derivative security
over six months ago at www.macroaxis.com 
Sale by Thomas Varvaro of 17996 shares of MabVax Therapeutics
Macroaxis News
Filed transaction by Mabvax Therapeutics Holdi director. General open market or private sale of non-derivative or derivative security

Total Debt

Total Debt Comparative Analysis
  Total Debt 
      MabVax Therapeutics Comparables 
MabVax Therapeutics is currently under evaluation in total debt category among related companies. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principle payments will eventually prevent the firm from borrow excessively.

Peers

MabVax Therapeutics Related Equities
TEVA  1.58 %   
0%
46.0%
NVS  0.38 %   
10.0%
0%
SHPG  0.47 %   
13.0%
0%
AZN  1.36 %   
39.0%
0%
NVO  1.51 %   
43.0%
0%
NBIX  1.92 %   
55.0%
0%
ALNY  2.1 %   
61.0%
0%
SNY  2.18 %   
63.0%
0%
GRFS  3.43 %   
100.0%
0%
Please see also Stocks Correlation. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.